Last reviewed · How we verify

NCT06632639

Effect of Lateral Wedged Insoles With Subtalar Strapping on Genu Varum With Medial Compartment Knee Pain

Recruiting now NA Last updated 26 November 2024
What this trial tests

NA trial testing Corrective exercise protocol in Genu Varum in 60 participants. Currently enrolling.

Timeline
12 November 2024
Primary endpoint
12 October 2025
31 October 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date12 November 2024
Primary completion12 October 2025
Estimated completion31 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Genu Varum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to investigate the effect of lateral wedged insoles with subtalar strapping in genu varum with medial compartment knee pain on: 1. Space between knees (measured by vernier calipers) 2. Degree of genu varum deformity (Femorotibial angle (FTA)) measured on long film weight bearing x-ray) 3. Pain level (Measured by VAS) 4. Hind foot angle (measured by long axial hindfoot alignment view) 5. Functional outcome (measured by the lower extremity function scale) 6. Functional performance (measured by the 6 minute walk test)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Genu Varum

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06632639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing